×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KOD – kodiak sciences inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KOD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/17
08:06 am
kod
Kodiak Sciences (NASDAQ:KOD) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
Low
Report
Kodiak Sciences (NASDAQ:KOD) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
11/17
08:06 am
kod
Kodiak Sciences (NASDAQ:KOD) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
Low
Report
Kodiak Sciences (NASDAQ:KOD) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
11/14
09:31 am
kod
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus [Yahoo! Finance]
Low
Report
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus [Yahoo! Finance]
11/12
05:56 pm
kod
Kodiak Sciences to Present at Upcoming Investor Conferences [Yahoo! Finance]
High
Report
Kodiak Sciences to Present at Upcoming Investor Conferences [Yahoo! Finance]
11/12
05:48 pm
kod
Kodiak Sciences to Present at Upcoming Investor Conferences
High
Report
Kodiak Sciences to Present at Upcoming Investor Conferences
11/11
08:08 am
kod
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $24.00 price target on the stock, up previously from $5.00.
Medium
Report
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $24.00 price target on the stock, up previously from $5.00.
11/5
07:00 am
kod
Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (=90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)
Low
Report
Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (=90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)
10/24
08:06 am
kod
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $24.00 price target on the stock, up previously from $15.00.
Low
Report
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $24.00 price target on the stock, up previously from $15.00.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/2
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
72.5%
12/4 Kodiak Sciences prices $276M equity offering [Seeking Alpha] 49.8%
9/15 Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting 17.2%
11/15 Form EFFECT Kodiak Sciences Inc. 16.6%
12/24 Kodiak Sciences Inc. (NYSE: KOD) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $82.00 price target on the stock. 15.3%
10/10 Form 8-K Kodiak Sciences Inc. For: Oct 04 13.3%
3/18 Form 4 Kodiak Sciences Inc. For: Mar 16 Filed by: BAKER FELIX 12.5%
5/15 Form S-8 Kodiak Sciences Inc. 12.2%
4/29 Form DEFA14A Kodiak Sciences Inc. 9.1%
9/4 Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting 8.3%
12/4 Kodiak Sciences prices $276M equity offering [Seeking Alpha] 49.8%
9/15 Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting 17.2%
11/15 Form EFFECT Kodiak Sciences Inc. 16.6%
12/24 Kodiak Sciences Inc. (NYSE: KOD) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $82.00 price target on the stock. 15.3%
10/10 Form 8-K Kodiak Sciences Inc. For: Oct 04 13.3%
3/18 Form 4 Kodiak Sciences Inc. For: Mar 16 Filed by: BAKER FELIX 12.5%
5/15 Form S-8 Kodiak Sciences Inc. 12.2%
4/29 Form DEFA14A Kodiak Sciences Inc. 9.1%
9/4 Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting 8.3%
TOP News Decliners
3/16
Q4/2019 12/31/2019 EPS -0.400 ZacksConsensus N/A ActVsEst N/A - N/A
-24.2%
12/4 Form 4 Kodiak Sciences Inc. For: Dec 02 Filed by: Liang Hong -11.0%
11/20 Form 8-K Kodiak Sciences Inc. For: Nov 18 -10.5%
8/14 Q2/2019 6/30/2019 EPS -0.310 ZacksConsensus N/A ActVsEst N/A - N/A -9.9%
2/26 Form SC 13D/A Kodiak Sciences Inc. Filed by: BAKER BROS. ADVISORS LP -8.4%
4/6 Form 4 Kodiak Sciences Inc. For: Apr 02 Filed by: Liang Hong -8.2%
12/2 Kodiak Sciences Inc. (NYSE: KOD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock. -7.9%
4/22 Form 4 Kodiak Sciences Inc. For: Apr 20 Filed by: EHRLICH JASON -6.9%
11/12 Q3/2019 9/30/2019 EPS -0.330 ZacksConsensus -0.330 ActVsEst 0.000 - In-Line -6.1%
11/18 3 Biotech Stock Rockets With More Fuel in the Tank [The Motley Fool] -5.6%
12/4 Form 4 Kodiak Sciences Inc. For: Dec 02 Filed by: Liang Hong -11.0%
11/20 Form 8-K Kodiak Sciences Inc. For: Nov 18 -10.5%
8/14 Q2/2019 6/30/2019 EPS -0.310 ZacksConsensus N/A ActVsEst N/A - N/A -9.9%
2/26 Form SC 13D/A Kodiak Sciences Inc. Filed by: BAKER BROS. ADVISORS LP -8.4%
4/6 Form 4 Kodiak Sciences Inc. For: Apr 02 Filed by: Liang Hong -8.2%
12/2 Kodiak Sciences Inc. (NYSE: KOD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock. -7.9%
4/22 Form 4 Kodiak Sciences Inc. For: Apr 20 Filed by: EHRLICH JASON -6.9%
11/12 Q3/2019 9/30/2019 EPS -0.330 ZacksConsensus -0.330 ActVsEst 0.000 - In-Line -6.1%
11/18 3 Biotech Stock Rockets With More Fuel in the Tank [The Motley Fool] -5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: